Industries > Pharma > Cancer Diagnostics Market Report 2019-2029
Cancer Diagnostics Market Report 2019-2029
Forecasts Technology (Platform-Based, Instrument Based, Tumor Biomarker Tests), Application (Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Prostate Cancer, Skin Cancer, Blood Cancer, Kidney Cancer, Pancreatic Cancer, Ovarian Cancer, Others), End-user (Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Others) Plus Analysis of Leading Companies
The comprehensive report offers market estimation and forecast for the period ranging 2019 – 2029 for leading national markets and the rest of the world. Moreover, the report contains dedicated leading companies covering 10 leading companies in the field of Cancer Diagnostics.
The Cancer Diagnostics Market 2019-2029 report will be of value to anyone who wants to better understand the cancer diagnostics market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the cancer diagnostics industry.
Cancer Diagnostics Market 2019-2029, By Technology
– Platform-Based
– Instrument-Based
– Tumor Biomarker Tests
Cancer Diagnostics Market 2019-2029, By Application
– Breast Cancer
– Colorectal Cancer
– Cervical Cancer
– Lung Cancer
– Prostate Cancer
– Skin Cancer
– Blood Cancer
– Kidney Cancer
– Pancreatic Cancer
– Ovarian Cancer
– Others
Cancer Diagnostics Market 2019-2029, End User
– Cancer Research Institutes
– Diagnostic Laboratories
– Hospitals
– Others
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Global Cancer Diagnostics Market Overview
1.2. Why You Should Read This Report
1.3. How This Report Delivers
1.4. Key Questions Answered by This Analytical Report Includes:
1.5. Who is This Report For?
1.6. Methodology
1.7. Frequently Asked Questions (FAQ)
1.8. Associated Visiongain Reports
1.9. About Visiongain
2. Introduction to the Cancer Diagnostics Market
2.1. What are Cancer Diagnostic Devices?
2.2. Types of Cancer Diagnostic Technology
2.2.1. Platform-Based
2.2.2. Instrument-Based
2.2.3. Tumor Biomarker Tests
2.3. Applications of Cancer Diagnostics
2.3.1. Breast Cancer
2.3.2. Colorectal Cancer
2.3.3. Cervical Cancer
2.3.4. Lung Cancer
2.3.5. Prostate Cancer
2.3.6. Skin Cancer
2.3.7. Blood Cancer
2.3.8. Kidney Cancer
2.3.9. Pancreatic Cancer
2.3.10. Ovarian Cancer
2.3.11. Others
2.4. Factors Impacting Cancer Diagnostics Market
3. Cancer Diagnostics Market Outlook
3.1. Trends in Cancer Diagnostics Industry
3.2. Market Drivers and Restraints
3.3. Cancer Diagnostics future opportunities
3.4. PESTEL Analysis
3.5. Industry Value Chain Analysis
3.6. Major Deals & Strategic Alliances Analysis
3.7. Market Entry Strategies
3.8. Industry Analysis – Porter’s
3.9. Cancer Diagnostics Market Analysis Tools
3.10. Regulatory Framework
3.11. Technology Overview
4. Cancer Diagnostics Market By Technology 2019 – 2029
4.1. Cancer Diagnostics Market Outlook By Technology 2019 – 2029
4.2. Platform-Based Revenue Forecast 2019 – 2029
4.3. Instrument-Based Revenue Forecast 2019 – 2029
4.4. Tumor Biomarker Tests Revenue Forecast 2019 – 2029
5. Cancer Diagnostics Market By Application 2019 – 2029
5.1. Cancer Diagnostics Market Outlook By Application 2019 – 2029
5.2. Breast Cancer Revenue Forecast 2019 – 2029
5.3. Colorectal Cancer Revenue Forecast 2019 – 2029
5.4. Cervical Cancer Revenue Forecast 2019 – 2029
5.5. Lung Cancer Revenue Forecast 2019 – 2029
5.6. Prostate Cancer Revenue Forecast 2019 – 2029
5.7. Skin Cancer Revenue Forecast 2019 – 2029
5.8. Blood Cancer Revenue Forecast 2019 – 2029
5.9. Kidney Cancer Revenue Forecast 2019 – 2029
5.10. Pancreatic Cancer Revenue Forecast 2019 – 2029
5.11. Ovarian Cancer Revenue Forecast 2019 – 2029
5.12. Others Cancer Revenue Forecast 2019 – 2029
6. Cancer Diagnostics Market By End User 2019 – 2029
6.1. Cancer Diagnostics Market Outlook By End User 2019 – 2029
6.2. Cancer Research Institutes Revenue Forecast 2019 – 2029
6.3. Diagnostic Laboratories Revenue Forecast 2019 – 2029
6.4. Hospitals Revenue Forecast 2019 – 2029
6.5. Others Revenue Forecast 2019 – 2029
7. Cancer Diagnostics Market By Region 2019 – 2029
7.1. Cancer Diagnostics Market Outlook By Region 2019 – 2029
7.2. North America Revenue Forecast 2019 – 2029
7.2.1. U.S. Revenue Forecast 2019 – 2029
7.2.2. Canada Revenue Forecast 2019 – 2029
7.3. Europe Revenue Forecast 2019 – 2029
7.3.1. Germany Revenue Forecast 2019 – 2029
7.3.2. UK Revenue Forecast 2019 – 2029
7.3.3. Russia Revenue Forecast 2019 – 2029
7.4. Asia Pacific Revenue Forecast 2019 – 2029
7.4.1. China Revenue Forecast 2019 – 2029
7.4.2. Japan Revenue Forecast 2019 – 2029
7.4.3. India Revenue Forecast 2019 – 2029
7.5. Rest of the World Revenue Forecast 2019 – 2029
7.5.1. Brazil Revenue Forecast 2019 – 2029
7.5.2. Saudi Arabia Revenue Forecast 2019 – 2029
8. The Leading Cancer Diagnostic Companies 2019 – 2029
8.1. Major Cancer Diagnostic Companies
8.2. Agilent Technologies
8.3. BioGenex
8.4. Siemens Healthcare GmbH
8.5. BioNTech Diagnostics GmbH
8.6. F. Hoffmann-La Roche Ltd
8.7. Thermo Fisher Scientific Inc.
8.8. Koninklijke Philips N.V.
8.9. NeoGenomics Laboratories, Inc.
8.10. bioMérieux SA
8.11. Abbott
8.12. Hologic Inc.
8.13. Illumina, Inc.
8.14. List of other companies
9. SWOT Analysis of The Cancer Diagnostics Market
10. Conclusions & Recommendations
10.1. Key Findings in the Cancer Diagnostics Market
10.2. Recommendations for the Cancer Diagnostics Market
11. Glossary
List of Tables
11.1. Global Cancer Diagnostics Market, 2019 & 2029 (USD billion)
11.2. Global Cancer Diagnostics Market, by Technology, 2019-2029 (USD billion)
11.3. Global Cancer Diagnostics Market, by Application, 2019-2029 (USD billion)
11.4. North America Cancer Diagnostics Market, by Technology, 2019-2029 (USD billion)
11.5. North America Cancer Diagnostics Market, by Application, 2019-2029 (USD billion)
11.6. North America Cancer Diagnostics Market, by Country, 2019-2029 (USD billion)
11.7. U.S. Cancer Diagnostics Market, by Technology, 2019-2029 (USD billion)
11.8. U.S. Cancer Diagnostics Market, by Application, 2019-2029 (USD billion)
11.9. Canada Cancer Diagnostics Market, by Technology, 2019-2029 (USD billion)
11.10. Canada Cancer Diagnostics Market, by Application, 2019-2029 (USD billion)
11.11. Europe Cancer Diagnostics Market, by Technology, 2019-2029 (USD billion)
11.12. Europe Cancer Diagnostics Market, by Application, 2019-2029 (USD billion)
11.13. Europe Cancer Diagnostics Market, by Country, 2019-2029 (USD billion)
11.14. Germany Cancer Diagnostics Market, by Technology, 2019-2029 (USD billion)
11.15. Germany Cancer Diagnostics Market, by Application, 2019-2029 (USD billion)
11.16. UK Cancer Diagnostics Market, by Technology, 2019-2029 (USD billion)
11.17. UK Cancer Diagnostics Market, by Application, 2019-2029 (USD billion)
11.18. Russia Cancer Diagnostics Market, by Technology, 2019-2029 (USD billion)
11.19. Russia Cancer Diagnostics Market, by Application, 2019-2029 (USD billion)
11.20. Asia Pacific Cancer Diagnostics Market, by Technology, 2019-2029 (USD billion)
11.21. Asia Pacific Cancer Diagnostics Market, by Application, 2019-2029 (USD billion)
11.22. Asia Pacific Cancer Diagnostics Market, by Country, 2019-2029 (USD billion)
11.23. Japan Cancer Diagnostics Market, by Technology, 2019-2029 (USD billion)
11.24. Japan Cancer Diagnostics Market, by Application, 2019-2029 (USD billion)
11.25. China Cancer Diagnostics Market, by Technology, 2019-2029 (USD billion)
11.26. China Cancer Diagnostics Market, by Application, 2019-2029 (USD billion)
11.27. India Cancer Diagnostics Market, by Technology, 2019-2029 (USD billion)
11.28. India Cancer Diagnostics Market, by Application, 2019-2029 (USD billion)
11.29. Rest of the World Cancer Diagnostics Market, by Technology, 2019-2029 (USD billion)
11.30. Rest of the World Cancer Diagnostics Market, by Application, 2019-2029 (USD billion)
11.31. Rest of the World Cancer Diagnostics Market, by Country, 2019-2029 (USD billion)
11.32. Brazil Cancer Diagnostics Market, by Technology, 2019-2029 (USD billion)
11.33. Brazil Cancer Diagnostics Market, by Application, 2019-2029 (USD billion)
11.34. Saudi Arabia Cancer Diagnostics Market, by Technology, 2019-2029 (USD billion)
11.35. Saudi Arabia Cancer Diagnostics Market, by Application, 2019-2029 (USD billion)
List of Figures
11.36. Research Methodology
11.37. Market Size Estimation Methodology
11.38. Forecasting Methodology
11.39. Global Cancer Diagnostics Market, DRO Analysis
11.40. Global Cancer Diagnostics Market, Company Share Analysis
11.41. Global Cancer Diagnostics Market, Interview Demographics
11.42. PESTEL Analysis
11.43. Global Cancer Diagnostics Market Segmentation
11.44. Global Cancer Diagnostics Market Share and Y-o-Y Growth, by Technology, 2019 & 2029
11.45. Global Cancer Diagnostics Market Share and Y-o-Y Growth, by Application, 2019-2029
11.46. Global Cancer Diagnostics Market Share and Y-o-Y Growth, by Geography, 2019-2029
11.47. North America Cancer Diagnostics Market Share and Y-o-Y Growth, by Technology, 2019 & 2029
11.48. North America Cancer Diagnostics Market Share and Y-o-Y Growth, by Application, 2019-2029
11.49. North America Cancer Diagnostics Market Share and Y-o-Y Growth, by Country, 2019-2029
11.50. Europe Cancer Diagnostics Market Share and Y-o-Y Growth, by Technology, 2019 & 2029
11.51. Europe Cancer Diagnostics Market Share and Y-o-Y Growth, by Application, 2019-2029
11.52. Europe Cancer Diagnostics Market Share and Y-o-Y Growth, by Country, 2019-2029
11.53. Asia Pacific Cancer Diagnostics Market Share and Y-o-Y Growth, by Technology, 2019 & 2029
11.54. Asia Pacific Cancer Diagnostics Market Share and Y-o-Y Growth, by Application, 2019-2029
11.55. Asia Pacific Cancer Diagnostics Market Share and Y-o-Y Growth, by Country, 2019-2029
11.56. Rest of the World Cancer Diagnostics Market Share and Y-o-Y Growth, by Technology, 2019 & 2029
11.57. Rest of the World Cancer Diagnostics Market Share and Y-o-Y Growth, by Application, 2019-2029
11.58. Rest of the World Cancer Diagnostics Market Share and Y-o-Y Growth, by Country, 2019-2029
Agilent Technologies
BioGenex
Siemens Healthcare GmbH
BioNTech Diagnostics GmbH
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc.
Koninklijke Philips N.V.
NeoGenomics Laboratories, Inc.
bioMérieux SA
Abbott
Hologic Inc.
Illumina, Inc.
Download sample pages
Complete the form below to download your free sample pages for Cancer Diagnostics Market Report 2019-2029Related reports
Cancer Immunotherapy Drug Discovery Outsourcing Market Report 2020-2030
Overall world revenue for Cancer Immunotherapy Drug Discovery Outsourcing will surpass $750 million in 2020, our work calculates. We predict...
Full DetailsPublished: 01 January 1970Cancer Tumour Profiling Market Report 2020-2030
The global cancer tumor profiling market is driven by the adoption of advanced cancer profiling methods by oncologists to diagnose,...
Full DetailsPublished: 01 January 1970Ovarian Cancer Drugs Market Report 2020-2030
Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
...Full DetailsPublished: 01 January 1970Precision Cancer Diagnostic Test Market Report 2021-2031
Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without,...Full DetailsPublished: 12 November 2020Cancer Supportive Care Drugs Market Report 2020-2030
Cancer has been primarily leading causes of death worldwide and most treatments for cancer come with various side effects such...
Full DetailsPublished: 01 January 1970
Download sample pages
Complete the form below to download your free sample pages for Cancer Diagnostics Market Report 2019-2029Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
What are the dynamic growth sectors? where are the regional business opportunities?
Which technologies will prevail and who are the leading companies succeeding in these sectors and why?
If you want definitive answers to business critical questions, discover Visiongain’s full range of business intelligence reports.
If so, please email Sara Peerun on sara.peerun@visiongain.com or call her today on +44 (0) 20 7549 9987
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Click here to ‘Like’ our Facebook page https://www.facebook.com/V.G.Pharma/
Latest Pharma news
Visiongain Publishes Bile Duct Cancer Drugs Market Report to 2031
The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.
22 February 2021
Visiongain Publishes Big Data Analytics in Healthcare Market Report to 2031
The global Big Data Analytics in Healthcare market has been growing considerably owing to the rising technological advancement, growing investment, and cohesive government policies.
22 February 2021
Visiongain Publishes Behavioural Health Market Report to 2031
The global behavioural Health market has been growing considerably owing to the rising pressure/stress at work, growing incidence and prevalence rate of depression and PTSD (Post Traumatic Stress Disorder) around the globe.
22 February 2021
Visiongain Publishes Beauty Supplements Market Report to 2031
The global Beauty Supplements market has been growing considerably owing to the growing urbanization, technological advancement, significant investment in the R&D process, and lifestyle changes around the globe.
22 February 2021